RETRACTED ARTICLE: Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection-Reference-Cited by-全球学者库

RETRACTED ARTICLE: Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection

Published:2014-04-17 Issue:1 Volume:14 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Lu Zhe-xin,Mao Li-li,Lian Feng,He Jun,Zhang Wen-tian,Dai Chen-yang,Xue Song,Lu Wei-gen,Zhu Hong-sheng

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1186/1471-2261-14-53.pdf

Reference31 articles.

1. Chi N-H, Yang M-C, Chung T-W, Chou N-K, Wang S-S: Cardiac repair using chitosan-hyaluronan/silk fibroin patches in a rat heart model with myocardial infarction. Carbohydr Polym. 2013, 92 (1): 591-597. 10.1016/j.carbpol.2012.09.012.

2. Li T-S, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H: Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol. 2012, 59 (10): 942-953. 10.1016/j.jacc.2011.11.029.

3. Gmeiner M, Zimpfer D, Holfeld J, Seebacher G, Abraham D, Grimm M, Aharinejad S: Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor. J Thorac Cardiovasc Surg. 2011, 141 (5): 1238-1245. 10.1016/j.jtcvs.2010.10.054.

4. Sutton MGSJ, Sharpe N: Left ventricular remodeling after myocardial infarction pathophysiology and therapy. Circulation. 2000, 101 (25): 2981-2988. 10.1161/01.CIR.101.25.2981.

5. Kandalam V, Basu R, Abraham T, Wang X, Soloway PD, Jaworski DM, Oudit GY, Kassiri Z: TIMP2 deficiency accelerates adverse post–myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation. Circ Res. 2010, 106 (4): 796-808. 10.1161/CIRCRESAHA.109.209189.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLGA nanoparticles for treatment of cardiovascular diseases;Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery;2023

2. Nanoplumbers: biomaterials to fight cardiovascular diseases;Materials Today;2018-03

3. Microparticles in Chronic Heart Failure;Advances in Clinical Chemistry;2017

4. Bioresorbable polymers for next-generation cardiac scaffolds;Bioresorbable Polymers for Biomedical Applications;2017

5. Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure;Current Drug Targets;2015-11-19